Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE34.0100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots32.2400/ 1
- Ask / Lots36.0000/ 3
- Open / Previous Close--- / 34.0100
- Day Range---
- 52 Week Range
- Volume30
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 5646 | 34.04 |
| 09:33 ET | 100 | 34.1 |
| 09:35 ET | 2300 | 34.275 |
| 09:37 ET | 3400 | 34.16 |
| 09:39 ET | 7200 | 34.0915 |
| 09:42 ET | 100 | 34 |
| 09:44 ET | 7200 | 34.13 |
| 09:46 ET | 600 | 34.085 |
| 09:48 ET | 6324 | 34.2 |
| 09:50 ET | 5513 | 34.21 |
| 09:51 ET | 525 | 34.32 |
| 09:53 ET | 1925 | 34.03 |
| 09:55 ET | 400 | 34.145 |
| 09:57 ET | 1800 | 34.4 |
| 10:00 ET | 1446 | 34.24 |
| 10:02 ET | 3100 | 34.36 |
| 10:04 ET | 5984 | 34.055 |
| 10:06 ET | 1800 | 34.31 |
| 10:08 ET | 2715 | 34.105 |
| 10:09 ET | 425 | 34.105 |
| 10:11 ET | 3159 | 33.96 |
| 10:13 ET | 622 | 33.64 |
| 10:15 ET | 837 | 33.66 |
| 10:18 ET | 893 | 33.66 |
| 10:20 ET | 1021 | 33.69 |
| 10:22 ET | 2500 | 33.98 |
| 10:24 ET | 660 | 34.09 |
| 10:26 ET | 1700 | 34.005 |
| 10:27 ET | 1645 | 33.87 |
| 10:29 ET | 2106 | 33.935 |
| 10:31 ET | 855 | 33.86 |
| 10:33 ET | 300 | 33.83 |
| 10:36 ET | 2835 | 33.88 |
| 10:38 ET | 4550 | 33.93 |
| 10:40 ET | 1400 | 34.025 |
| 10:42 ET | 840 | 34.025 |
| 10:44 ET | 9333 | 33.755 |
| 10:45 ET | 500 | 33.725 |
| 10:47 ET | 900 | 33.725 |
| 10:49 ET | 4904 | 33.885 |
| 10:51 ET | 251 | 33.91 |
| 10:54 ET | 516 | 33.785 |
| 10:56 ET | 1300 | 33.78 |
| 10:58 ET | 2726 | 34.02 |
| 11:00 ET | 510 | 33.89 |
| 11:02 ET | 300 | 33.855 |
| 11:03 ET | 399 | 33.95 |
| 11:05 ET | 609 | 33.94 |
| 11:07 ET | 500 | 33.98 |
| 11:09 ET | 1302 | 33.925 |
| 11:12 ET | 1619 | 33.675 |
| 11:14 ET | 13525 | 33.855 |
| 11:16 ET | 100 | 33.845 |
| 11:20 ET | 1547 | 33.91 |
| 11:21 ET | 397 | 33.8 |
| 11:25 ET | 965 | 33.99 |
| 11:27 ET | 1155 | 34.05 |
| 11:30 ET | 200 | 34 |
| 11:34 ET | 1400 | 34.2 |
| 11:36 ET | 1000 | 34.04 |
| 11:38 ET | 500 | 33.85 |
| 11:39 ET | 532 | 34.03 |
| 11:41 ET | 700 | 34.115 |
| 11:43 ET | 1000 | 33.99 |
| 11:45 ET | 8014 | 33.92 |
| 11:48 ET | 1515 | 33.75 |
| 11:50 ET | 1508 | 33.68 |
| 11:52 ET | 1600 | 33.9 |
| 11:54 ET | 200 | 33.76 |
| 11:56 ET | 200 | 33.8017 |
| 11:57 ET | 2383 | 33.905 |
| 11:59 ET | 104324 | 33.975 |
| 12:01 ET | 600 | 34.01 |
| 12:03 ET | 965 | 34.01 |
| 12:06 ET | 1000 | 33.9591 |
| 12:08 ET | 111365 | 33.8475 |
| 12:10 ET | 8325 | 33.99 |
| 12:12 ET | 1386 | 34.18 |
| 12:14 ET | 3741 | 33.985 |
| 12:15 ET | 500 | 33.97 |
| 12:17 ET | 1385 | 34.01 |
| 12:19 ET | 1156 | 33.945 |
| 12:21 ET | 1325 | 34.04 |
| 12:24 ET | 3190 | 33.95 |
| 12:26 ET | 2800 | 33.95 |
| 12:28 ET | 1800 | 34.06 |
| 12:30 ET | 1395 | 34.0888 |
| 12:33 ET | 900 | 34.15 |
| 12:35 ET | 1200 | 34.15 |
| 12:37 ET | 400 | 34.28 |
| 12:39 ET | 200 | 34.14 |
| 12:42 ET | 500 | 34.21 |
| 12:44 ET | 3594 | 34.26 |
| 12:46 ET | 500 | 34.26 |
| 12:50 ET | 1300 | 34.215 |
| 12:51 ET | 200 | 34.205 |
| 12:53 ET | 1945 | 34.25 |
| 12:55 ET | 1140 | 34.27 |
| 12:57 ET | 1393 | 34.25 |
| 01:00 ET | 1267 | 34.215 |
| 01:02 ET | 2444 | 34.15 |
| 01:04 ET | 4002 | 34.2 |
| 01:06 ET | 249 | 34.265 |
| 01:08 ET | 1987 | 34.25 |
| 01:09 ET | 800 | 34.2 |
| 01:11 ET | 3697 | 34.37 |
| 01:13 ET | 1500 | 34.46 |
| 01:15 ET | 184 | 34.4 |
| 01:18 ET | 562 | 34.37 |
| 01:20 ET | 100 | 34.27 |
| 01:22 ET | 600 | 34.24 |
| 01:24 ET | 1649 | 34.3 |
| 01:26 ET | 400 | 34.27 |
| 01:27 ET | 500 | 34.2675 |
| 01:29 ET | 300 | 34.27 |
| 01:31 ET | 2948 | 34.265 |
| 01:33 ET | 3150 | 34.27 |
| 01:36 ET | 300 | 34.285 |
| 01:38 ET | 1445 | 34.28 |
| 01:40 ET | 100 | 34.29 |
| 01:42 ET | 300 | 34.24 |
| 01:44 ET | 100 | 34.24 |
| 01:45 ET | 200 | 34.21 |
| 01:49 ET | 100 | 34.21 |
| 01:51 ET | 1299 | 34.24 |
| 01:54 ET | 3445 | 34.33 |
| 01:56 ET | 1600 | 34.39 |
| 01:58 ET | 248 | 34.47 |
| 02:00 ET | 200 | 34.41 |
| 02:02 ET | 2715 | 34.5 |
| 02:03 ET | 1800 | 34.37 |
| 02:07 ET | 600 | 34.38 |
| 02:12 ET | 200 | 34.34 |
| 02:16 ET | 2203 | 34.45 |
| 02:18 ET | 100 | 34.39 |
| 02:20 ET | 200 | 34.39 |
| 02:21 ET | 100 | 34.42 |
| 02:23 ET | 200 | 34.37 |
| 02:25 ET | 1280 | 34.3 |
| 02:27 ET | 748 | 34.26 |
| 02:30 ET | 3652 | 34.27 |
| 02:32 ET | 2200 | 34.35 |
| 02:34 ET | 100 | 34.29 |
| 02:36 ET | 600 | 34.3 |
| 02:38 ET | 100 | 34.27 |
| 02:39 ET | 1290 | 34.31 |
| 02:41 ET | 900 | 34.305 |
| 02:43 ET | 665 | 34.34 |
| 02:45 ET | 800 | 34.315 |
| 02:48 ET | 1000 | 34.26 |
| 02:50 ET | 4866 | 34.2 |
| 02:52 ET | 2156 | 34.29 |
| 02:54 ET | 348 | 34.26 |
| 02:56 ET | 4987 | 34.2 |
| 02:57 ET | 1382 | 34.08 |
| 02:59 ET | 155354 | 33.89 |
| 03:01 ET | 1816 | 34.02 |
| 03:03 ET | 500 | 34.03 |
| 03:06 ET | 2050 | 33.9 |
| 03:08 ET | 898 | 34.14 |
| 03:10 ET | 600 | 33.99 |
| 03:12 ET | 1365 | 34.16 |
| 03:14 ET | 1560 | 33.995 |
| 03:15 ET | 100 | 34 |
| 03:17 ET | 2321 | 33.94 |
| 03:19 ET | 100 | 33.92 |
| 03:21 ET | 401 | 33.97 |
| 03:24 ET | 10701 | 33.965 |
| 03:26 ET | 2145 | 33.985 |
| 03:28 ET | 754 | 33.985 |
| 03:30 ET | 1539 | 33.99 |
| 03:32 ET | 2920 | 33.99 |
| 03:33 ET | 1565 | 34.02 |
| 03:35 ET | 1947 | 34.12 |
| 03:37 ET | 100 | 34.11 |
| 03:39 ET | 738 | 34.03 |
| 03:42 ET | 1152 | 34.01 |
| 03:44 ET | 4359 | 33.965 |
| 03:46 ET | 10206 | 33.965 |
| 03:48 ET | 2380 | 33.995 |
| 03:50 ET | 1279 | 33.91 |
| 03:51 ET | 10623 | 34.03 |
| 03:53 ET | 5733 | 34.035 |
| 03:55 ET | 6952 | 34.05 |
| 03:57 ET | 14970 | 34.07 |
| 04:00 ET | 21877 | 34.04 |
Nov 15, 2024
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference, from 8:30AM ET on Friday Nov 15, 2024 by Dow Jones
8:30AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 13, 2024
Press Release: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow JonesStructure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow JonesStructure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity, from 4:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
Oct 31, 2024
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek(R) 2024, from 8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 1.9B | -15.4x | --- |
Disc Medicine Inc | 1.9B | -16.3x | --- |
NewAmsterdam Pharma Company NV | 1.9B | -9.4x | --- |
Celldex Therapeutics Inc | 1.8B | -11.0x | --- |
Tarsus Pharmaceuticals Inc | 1.8B | -12.9x | --- |
Spyre Therapeutics Inc | 1.6B | -3.7x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Chief Executive Officer, Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.21 |
Book Value | $9.76 |
P/E Ratio | -15.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
